FDA Releases Model DFLs, Comprehension Study For OTC Naloxone

In an effort to encourage drug companies to develop over-the-counter (OTC) versions of overdose-reversal drug naloxone, FDA has developed a model drug facts label with pictograms that show how to use the drug, which can help consumers better understand how to use naloxone without the supervision of a health care professional, agency chief Scott Gottlieb announced on Thursday (Jan. 17). This is the first time, according to Gottlieb, that FDA has developed and tested a DFL for a drug to...